Eribulin mesylate exerts antitumor effects via CD103
Eribulin mesylate (ERB) is a synthetic analog of halichondrin B, inhibiting tumor cell growth by disrupting microtubule function. Recently, anticancer drugs have been shown to not only act directly on tumor cells but also to exert antitumor effects by modifying the tumor environment. Although ERB ha...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis Group
2023-12-01
|
| Collection: | OncoImmunology |
| Sujets: | |
| Accès en ligne: | https://www.tandfonline.com/doi/10.1080/2162402X.2023.2218782 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|